BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8969177)

  • 1. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
    Itabe H; Yamamoto H; Suzuki M; Kawai Y; Nakagawa Y; Suzuki A; Imanaka T; Takano T
    J Biol Chem; 1996 Dec; 271(52):33208-17. PubMed ID: 8969177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.
    Itabe H; Takeshima E; Iwasaki H; Kimura J; Yoshida Y; Imanaka T; Takano T
    J Biol Chem; 1994 May; 269(21):15274-9. PubMed ID: 8195164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
    Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
    J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
    Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
    J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
    Itabe H; Suzuki K; Tsukamoto Y; Komatsu R; Ueda M; Mori M; Higashi Y; Takano T
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):233-45. PubMed ID: 11018475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
    Itabe H
    Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
    Sasabe N; Keyamura Y; Obama T; Inoue N; Masuko Y; Igarashi Y; Aiuchi T; Kato R; Yamaguchi T; Kuwata H; Iwamoto S; Miyazaki A; Hara S; Yoshikawa T; Itabe H
    Lipids Health Dis; 2014 Mar; 13():48. PubMed ID: 24625108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
    Itabe H
    Biol Pharm Bull; 2003 Jan; 26(1):1-9. PubMed ID: 12520163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
    Kohno H; Sueshige N; Oguri K; Izumidate H; Masunari T; Kawamura M; Itabe H; Takano T; Hasegawa A; Nagai R
    Clin Biochem; 2000 Jun; 33(4):243-53. PubMed ID: 10936581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
    Boyd HC; Gown AM; Wolfbauer G; Chait A
    Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.
    Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Gugiu B; Fox PL; Hoff HF; Salomon RG; Hazen SL
    J Biol Chem; 2002 Oct; 277(41):38503-16. PubMed ID: 12105195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
    Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
    J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.
    Chang MK; Binder CJ; Torzewski M; Witztum JL
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13043-8. PubMed ID: 12244213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipids in oxidized low density lipoproteins perturb the ability of macrophages to degrade internalized macromolecules and reduce intracellular cathepsin B activity.
    O'Neil J; Hoppe G; Hoff HF
    Atherosclerosis; 2003 Aug; 169(2):215-24. PubMed ID: 12921972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
    Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
    J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
    Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination between minimally modified LDL and fully oxidized LDL using monoclonal antibodies.
    Lowhalidanon K; Khunkaewla P
    Anal Biochem; 2021 Apr; 619():114103. PubMed ID: 33453163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells.
    Bird DA; Gillotte KL; Hörkkö S; Friedman P; Dennis EA; Witztum JL; Steinberg D
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6347-52. PubMed ID: 10339590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.